A Phase 3, Open-Label Extension Study To Assess The Long-Term Safety Of Karxt For The Treatment Of Mania Or Mania With Mixed Features In Bipolar-I Disorder (Balsam-3)
Posted Date: Jul 10, 2025
- Investigator: Caleb Adler
- Specialties:
- Type of Study: Drug
The purpose of this research is to learn about the long-term safety of the study drug, KarXT for the treatment of Mania or Mania with mixed features in Bipolar-1 Disorder
Criteria:
Null
Keywords:
Mania, Bipolar Disorder
For More Information:
Karen Tugrul
5135586831
tugrulkc@ucmail.uc.edu